Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$46.84 - $59.75 $1.41 Million - $1.79 Million
-30,000 Reduced 85.71%
5,000 $246,000
Q1 2022

May 12, 2022

BUY
$48.09 - $57.79 $432,810 - $520,110
9,000 Added 34.62%
35,000 $1.99 Million
Q4 2021

Feb 11, 2022

BUY
$47.19 - $62.68 $424,710 - $564,120
9,000 Added 52.94%
26,000 $1.36 Million
Q4 2020

Feb 12, 2021

BUY
$43.41 - $56.51 $260,459 - $339,060
6,000 Added 54.55%
17,000 $958,000
Q3 2020

Nov 12, 2020

BUY
$47.43 - $60.75 $332,010 - $425,250
7,000 Added 175.0%
11,000 $534,000
Q2 2020

Aug 13, 2020

BUY
$43.51 - $66.59 $174,040 - $266,360
4,000 New
4,000 $223,000

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track King Wealth Portfolio

Follow King Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of King Wealth, based on Form 13F filings with the SEC.

News

Stay updated on King Wealth with notifications on news.